NanJing Pharmaceutical Co Ltd (600713) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.119x

Based on the latest financial reports, NanJing Pharmaceutical Co Ltd (600713) has a cash flow conversion efficiency ratio of -0.119x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-942.93 Million ≈ $-137.98 Million USD) by net assets (CN¥7.95 Billion ≈ $1.16 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see NanJing Pharmaceutical Co Ltd market capitalisation for the company's overall valuation and market capitalisation.

NanJing Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how NanJing Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

NanJing Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NanJing Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore how high is NanJing Pharmaceutical Co Ltd's earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Ficont Industry (Beijing) Co. Ltd. SHG:605305	0.028x
China High-Speed Railway Technology SHE:000008	0.015x
Xinke Material SHG:600255	-0.100x
Zhe Jiang Headman Machinery Co Ltd SHG:688577	0.075x
Indo Count Industries Limited NSE:ICIL	0.156x
Seneca Foods Corp A NASDAQ:SENEA	0.141x
Daxin Materials Corp TW:5234	0.068x
CWB Automotive Electronics Co Ltd SHG:605005	0.056x

Annual Cash Flow Conversion Efficiency for NanJing Pharmaceutical Co Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of NanJing Pharmaceutical Co Ltd from 1998 to 2024. View NanJing Pharmaceutical Co Ltd stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥7.79 Billion ≈ $1.14 Billion	CN¥2.14 Billion ≈ $312.53 Million	0.274x	+4.36%
2023-12-31	CN¥7.25 Billion ≈ $1.06 Billion	CN¥1.91 Billion ≈ $278.97 Million	0.263x	+357.83%
2022-12-31	CN¥6.69 Billion ≈ $979.67 Million	CN¥-682.31 Million ≈ $-99.84 Million	-0.102x	-176.71%
2021-12-31	CN¥5.23 Billion ≈ $765.86 Million	CN¥695.33 Million ≈ $101.75 Million	0.133x	+155.57%
2020-12-31	CN¥4.82 Billion ≈ $705.34 Million	CN¥-1.15 Billion ≈ $-168.64 Million	-0.239x	-207.64%
2019-12-31	CN¥4.52 Billion ≈ $661.42 Million	CN¥1.00 Billion ≈ $146.91 Million	0.222x	+348.76%
2018-12-31	CN¥4.11 Billion ≈ $601.30 Million	CN¥-366.90 Million ≈ $-53.69 Million	-0.089x	-188.92%
2017-12-31	CN¥3.19 Billion ≈ $466.29 Million	CN¥319.99 Million ≈ $46.82 Million	0.100x	+227.96%
2016-12-31	CN¥3.07 Billion ≈ $449.14 Million	CN¥-240.88 Million ≈ $-35.25 Million	-0.078x	+31.12%
2015-12-31	CN¥2.69 Billion ≈ $393.13 Million	CN¥-306.08 Million ≈ $-44.79 Million	-0.114x	+18.57%
2014-12-31	CN¥2.44 Billion ≈ $356.66 Million	CN¥-341.01 Million ≈ $-49.90 Million	-0.140x	+49.13%
2013-12-31	CN¥1.29 Billion ≈ $188.48 Million	CN¥-354.27 Million ≈ $-51.84 Million	-0.275x	-314.86%
2012-12-31	CN¥1.31 Billion ≈ $192.23 Million	CN¥168.17 Million ≈ $24.61 Million	0.128x	+125.10%
2011-12-31	CN¥1.36 Billion ≈ $198.74 Million	CN¥-692.53 Million ≈ $-101.34 Million	-0.510x	-641.23%
2010-12-31	CN¥1.26 Billion ≈ $184.95 Million	CN¥119.08 Million ≈ $17.42 Million	0.094x	+247.07%
2009-12-31	CN¥744.78 Million ≈ $108.98 Million	CN¥20.22 Million ≈ $2.96 Million	0.027x	+283.11%
2008-12-31	CN¥610.69 Million ≈ $89.36 Million	CN¥4.33 Million ≈ $633.18K	0.007x	-93.87%
2007-12-31	CN¥700.93 Million ≈ $102.57 Million	CN¥81.08 Million ≈ $11.86 Million	0.116x	-53.82%
2006-12-31	CN¥643.97 Million ≈ $94.23 Million	CN¥161.31 Million ≈ $23.61 Million	0.250x	-2.12%
2005-12-31	CN¥646.94 Million ≈ $94.67 Million	CN¥165.57 Million ≈ $24.23 Million	0.256x	+866.48%
2004-12-31	CN¥614.14 Million ≈ $89.87 Million	CN¥16.26 Million ≈ $2.38 Million	0.026x	-15.90%
2003-12-31	CN¥611.84 Million ≈ $89.53 Million	CN¥19.27 Million ≈ $2.82 Million	0.031x	-76.86%
2002-12-31	CN¥505.29 Million ≈ $73.94 Million	CN¥68.75 Million ≈ $10.06 Million	0.136x	+1628.15%
2001-12-31	CN¥472.04 Million ≈ $69.07 Million	CN¥-4.20 Million ≈ $-615.03K	-0.009x	-104.94%
2000-12-31	CN¥486.93 Million ≈ $71.25 Million	CN¥87.68 Million ≈ $12.83 Million	0.180x	+58.29%
1999-12-31	CN¥444.61 Million ≈ $65.06 Million	CN¥50.58 Million ≈ $7.40 Million	0.114x	-37.30%
1998-12-31	CN¥426.92 Million ≈ $62.47 Million	CN¥77.45 Million ≈ $11.33 Million	0.181x	--

About NanJing Pharmaceutical Co Ltd

SHG:600713 China Drug Manufacturers - General

Market Cap

$961.52 Million

CN¥6.57 Billion CNY

Market Cap Rank

#9206 Global

#2323 in China

Share Price

CN¥5.02

Change (1 day)

-1.18%

52-Week Range

CN¥4.84 - CN¥6.40

All Time High

CN¥10.55